Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,358 | 401 | 96.9% |
| Education | $299.05 | 7 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,485 | 95 | $0 (2024) |
| Amgen Inc. | $1,404 | 57 | $0 (2024) |
| Janssen Biotech, Inc. | $1,047 | 59 | $0 (2024) |
| Lilly USA, LLC | $679.92 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $629.50 | 21 | $0 (2024) |
| UCB, Inc. | $464.23 | 25 | $0 (2024) |
| Horizon Therapeutics plc | $450.60 | 8 | $0 (2023) |
| PFIZER INC. | $449.71 | 30 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $336.35 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $309.62 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,802 | 138 | ABBVIE INC. ($959.32) |
| 2023 | $3,943 | 163 | ABBVIE INC. ($737.43) |
| 2022 | $2,650 | 104 | Amgen Inc. ($636.65) |
| 2021 | $262.12 | 3 | AbbVie Inc. ($153.32) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Immunology | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 864 | 3,233 | $235,848 | $79,026 |
| 2022 | 13 | 711 | 2,398 | $168,644 | $57,859 |
| 2021 | 9 | 411 | 602 | $70,372 | $21,501 |
| 2020 | 1 | 12 | 12 | $13,380 | $1,016 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,740 | $59,160 | $32,437 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 147 | $36,750 | $11,649 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 200 | $40,000 | $10,305 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 57 | $17,100 | $6,393 | 37.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 64 | $32,000 | $5,489 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $17,000 | $5,003 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 147 | 254 | $2,540 | $2,134 | 84.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 39 | $12,900 | $1,817 | 14.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 114 | 194 | $4,850 | $1,476 | 30.4% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 103 | 172 | $4,300 | $718.96 | 16.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 13 | 23 | $1,495 | $563.73 | 37.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 16 | 16 | $1,920 | $504.32 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 39 | $1,950 | $356.44 | 18.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 171 | $1,881 | $139.39 | 7.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 15 | 77 | $2,002 | $39.27 | 2.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,320 | $44,880 | $22,879 | 51.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 103 | 119 | $35,700 | $12,448 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 120 | $30,000 | $8,740 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 86 | $17,200 | $4,825 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $13,175 | $3,977 | 30.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 32 | $12,000 | $1,444 | 12.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 87 | 139 | $3,475 | $1,064 | 30.6% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 19 | 33 | $2,145 | $804.74 | 37.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 121 | 190 | $1,900 | $561.60 | 29.6% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 81 | 131 | $3,275 | $550.88 | 16.8% |
About Timothy Cassidy
Timothy Cassidy is a Physician Assistant healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2019. The National Provider Identifier (NPI) number assigned to this provider is 1750948287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Timothy Cassidy has received a total of $9,657 in payments from pharmaceutical and medical device companies, with $2,802 received in 2024. These payments were reported across 408 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($9,358).
As a Medicare-enrolled provider, Cassidy has provided services to 1,998 Medicare beneficiaries, totaling 6,245 services with total Medicare billing of $159,402. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Albany, NY
- Active Since 05/20/2019
- Last Updated 02/08/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750948287
Products in Payments
- RINVOQ (Biological) $1,804
- TREMFYA (Drug) $991.49
- TALTZ (Drug) $655.70
- BENLYSTA (Biological) $629.50
- Enbrel (Biological) $551.68
- KRYSTEXXA (Biological) $539.38
- SKYRIZI (Biological) $477.43
- XELJANZ (Drug) $449.71
- Cimzia (Drug) $404.02
- ACTHAR (Biological) $336.35
- EVENITY (Biological) $268.39
- COSENTYX (Drug) $249.47
- Tavneos (Drug) $175.97
- OFEV (Drug) $145.68
- LUPKYNIS (Drug) $144.04
- Otezla (Drug) $133.45
- AMJEVITA (Biological) $132.81
- Actemra (Biological) $132.31
- RENFLEXIS (Drug) $124.90
- ORENCIA (Biological) $112.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Albany
Richard Dalaba, Rpa-C, RPA-C
Physician Assistant — Payments: $25,244
Michael Weinberg, Rpa-C, RPA-C
Physician Assistant — Payments: $15,507
Brandon Glow, Pa, PA
Physician Assistant — Payments: $12,434
Mr. Richard Clark, Rpa-C, RPA-C
Physician Assistant — Payments: $12,243
Brittany Baxter
Physician Assistant — Payments: $11,994
Maura Corbett, Pa-C, PA-C
Physician Assistant — Payments: $10,670